---
layout: post
title: "Prospective Grant of an Exclusive Patent License: Methods for the Diagnosis and Prognosis of Cancer"
date: 2026-02-04 21:46:43 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-20290
original_published: 2025-11-19 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: Methods for the Diagnosis and Prognosis of Cancer

**Published:** February 04, 2026 21:46 UTC
**Source:** Federal Register
**Original Published:** November 19, 2025 00:00 UTC
**Document Number:** 2025-20290

## Summary

The National Cancer Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patent applications listed in the SUPPLEMENTARY INFORMATION section of this notice to BioncoDx, LLC, a company organized in Delaware.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/11/19/2025-20290/prospective-grant-of-an-exclusive-patent-license-methods-for-the-diagnosis-and-prognosis-of-cancer)
- API: https://www.federalregister.gov/api/v1/documents/2025-20290

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
